The Preparation, Handling and Use of Intravesical Bacillus Calmette-Guerin for the Management of Stage Ta, T1, Carcinoma in Situ and Transitional Cell Cancer

Abstract

The increasing use of bacillus Calmette-Guerin in the treatment of patients with low stage bladder cancer will inevitably bring attention to problems of proper use and toxicity. There is a need to identify patients who are most likely to benefit from this therapy and those who may be at risk for serious complications.